923948-66-7Relevant academic research and scientific papers
DIAZEPINE AND DIAZOCANE COMPOUNDS AS MC4 AGONISTS
-
Page/Page column 97, (2010/04/03)
The present invention relates to compounds of formula (I) wherein R1, R2, R3, R4, L and n are as defined in the specification. These compounds are useful as MC4 agonists.
MELANOCORTIN RECEPTOR AGONISTS
-
Page/Page column 13, (2010/06/11)
The present invention relates to a compound having a good agonistic activity to melanocortin receptor, or pharmaceutically acceptable salt or isomer thereof, and an agonistic composition for melanocortin receptor comprising the same as an active ingredient.
MELANOCORTIN RECEPTOR AGONISTS
-
Page/Page column 29-30, (2010/06/15)
The present invention relates to a compound having a good agonistic activity to melanocortin receptor, or pharmaceutically acceptable salt or isomer thereof, and an agonistic composition for melanocortin receptor comprising the same as an active ingredient.
Use of Mc4 Receptor Agonist Compounds
-
Page/Page column 30-31, (2008/12/08)
This invention relates to the use of an MC4 receptor agonist compound for the manufacture of a medicament for the treatment of lower urinary tract dysfunction.
PIPERIDINOYL-PYRROLIDINE AND PIPERIDINOYL-PIPERIDINE COMPOUNDS
-
Page/Page column 72-73, (2010/11/25)
The present invention relates to a class of compounds of general formula (I) and the salts, hydrates, solvates, polymorphs and prodrugs wherein n, R6, R7 and R10 are as defined herein and especially to MCR4 agonist compounds of formula (I), to their use in medicine, particularly in the treatment of sexual dysfunction and obesity, to intermediates useful in their synthesis and to compositions containing them.
